HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuichi Teraki Selected Research

Interleukin-13

10/2013IL-13/IL-22-coproducing T cells, a novel subset, are increased in atopic dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuichi Teraki Research Topics

Disease

7Drug Eruptions (Drug Eruption)
02/2008 - 08/2002
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 04/2018
4Stevens-Johnson Syndrome (Lyell's Syndrome)
12/2019 - 01/2006
3Hypersensitivity (Allergy)
01/2017 - 02/2008
3Eosinophilia
01/2017 - 02/2008
3Skin Diseases (Skin Disease)
09/2003 - 08/2002
2Kimura Disease
01/2022 - 01/2002
2Dermatitis
04/2018 - 01/2012
2Exanthema (Rash)
01/2017 - 02/2008
1Bullous Pemphigoid (Pemphigoid)
09/2022
1Pruritus (Itching)
09/2022
1Blister (Bulla)
09/2022
1Fibrosis (Cirrhosis)
01/2022
1Fatty Liver
01/2022
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
04/2021
1Sarcoidosis (Schaumann Disease)
06/2020
1Fatigue
03/2020
1Weight Gain
09/2018
1Immunoglobulin G4-Related Disease
09/2016
1Hematologic Neoplasms (Hematological Malignancy)
04/2016
1Clear Cell Sarcoma
06/2015
1Neoplasms (Cancer)
06/2015
1Ewing Sarcoma (Sarcoma, Ewing)
06/2015
1Disease Progression
06/2015
1Folliculitis (Sycosis)
01/2015
1Atopic Dermatitis (Atopic Eczema)
10/2013
1Rosacea (Acne Rosacea)
01/2012
1Angioedema
10/2007
1Inflammation (Inflammations)
08/2002

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
01/2017 - 08/2002
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 04/2018
2CytokinesIBA
09/2022 - 09/2003
2dupilumabIBA
09/2022 - 01/2022
2Biological ProductsIBA
11/2020 - 03/2020
2InterleukinsIBA
09/2018 - 09/2016
1AntibodiesIBA
09/2022
1guselkumabIBA
04/2021
1ColchicineFDA LinkGeneric
11/2020
1Minocycline (Cyclops)FDA LinkGeneric
06/2020
1Tetracycline (Achromycin)FDA LinkGeneric
06/2020
1apremilastIBA
03/2020
1mogamulizumabIBA
12/2019
1secukinumabIBA
09/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2018
1Interleukin-23 (Interleukin 23)IBA
09/2018
1Ustekinumab (CNTO 1275)FDA Link
09/2018
1Infliximab (Remicade)FDA Link
09/2018
1S100 Proteins (S 100 Protein)IBA
06/2015
1Phosphopyruvate Hydratase (Enolase)IBA
06/2015
1Biomarkers (Surrogate Marker)IBA
06/2015
1Activating Transcription Factor 1IBA
06/2015
1MART-1 AntigenIBA
06/2015
1Nylons (Nylon)IBA
01/2015
1Interleukin-13IBA
10/2013
1Calcineurin InhibitorsIBA
01/2012
1Tacrolimus (Prograf)FDA LinkGeneric
01/2012
1Ointments (Pastes)IBA
01/2012
1Immunoglobulin G (IgG)IBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
02/2008
1Zonisamide (Zonegran)FDA LinkGeneric
02/2008
1Leflunomide (Arava)FDA LinkGeneric
11/2006
1Terbinafine (Lamisil)FDA LinkGeneric
01/2004
1Interferon-gamma (Interferon, gamma)IBA
10/2002
1AntigensIBA
08/2002
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2002

Therapy/Procedure

3Therapeutics
11/2020 - 03/2020
1Aftercare (After-Treatment)
09/2022
1Biological Therapy
03/2020
1Transplantation
04/2016